Virginia Retirement Systems Et Al Macrogenics Inc Transaction History

Virginia Retirement Systems Et Al

7 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2021 Aug 13, 2021	SELL	$20.49 - $35.63 $243,830 - $423,997	-11,900 Closed	0 $0
Q1 2021 Apr 30, 2021	BUY	$18.99 - $33.2 $18,990 - $33,200	1,000 Added 9.17%	11,900 $379,000
Q4 2020 Feb 16, 2021	BUY	$19.41 - $26.0 $21,351 - $28,600	1,100 Added 11.22%	10,900 $249,000
Q3 2020 Nov 12, 2020	SELL	$24.69 - $31.6 $34,566 - $44,240	-1,400 Reduced 12.5%	9,800 $247,000
Q2 2020 Aug 12, 2020	BUY	$5.2 - $29.12 $58,240 - $326,144	11,200 New	11,200 $313,000

Q1 2019 Apr 25, 2019	SELL	$11.11 - $25.6 $265,529 - $611,840	-23,900 Closed	0 $0
Q4 2018 Feb 07, 2019	BUY	$11.75 - $21.42 $280,825 - $511,938	23,900 New	23,900 $304,000

111

50M

65.5K

93.9K

Ticker MGNX
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 61,458,800
Market Cap $94.6M
Description
MacroGenics, Inc., a biopharmaceutical company, develops and commercializes antibody-based therapeutics to treat cancer in the United States. Its approved product is MARGENZA (margetuximab-cmkb), a human epidermal growth factor receptor 2 (HER2) receptor antagonist indicated, in combination with chemotherapy, for the treatment of adult patients ...

Get notified when there are updates to the investment portfolio of Virginia Retirement Systems Et Al, based on Form 13F filings with the SEC.

Stay updated on Virginia Retirement Systems Et Al with notifications on news.